Andrew Dudum
Andrew Dudum is the co-founder and chief executive officer of Hims & Hers Health Inc., a prominent U.S. telehealth provider. Under his leadership, the company has expanded its services internationally, recently acquiring the Canadian telehealth company Livewell to tap into the growing demand for affordable weight-loss medications such as semaglutide. Dudum emphasizes the importance of addressing the obesity crisis and aims to provide advanced therapies to Canadians, as the market for generic Ozempic is expected to open soon. His strategic vision involves using Canada as a model for future expansions into other global markets.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Hims' CEO Andrew Dudum accused Novo of attempting to control how clinicians at Hims make decisions.
4
Denmark:
Andrew Dudum, the CEO of Hims and Hers, expressed excitement about launching the Wegovy copy.
8
Canada:
Andrew Dudum, co-founder and chief executive officer of Hims & Hers, said Canada presented a major opportunity for the company’s next international expansion.
8